CONSTITUTIVELY ACTIVE PTH/PTHRP RECEPTORS IN OSTEOBLAST
CONSTITUTIVELY ACTIVE PTH/PTHRP RECEPTORS IN OSTEOBLAST
批准号:
6100690
负责人:
Ernestina Schipani
金额:
$19.19万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-01 至 1999-08-31
关键词:
bone development bone metabolism collagenase cyclic AMP enzyme induction /repression genetic promoter element genetically modified animals hormone receptor hormone regulation /control mechanism laboratory mouse osteoblasts osteoclasts parathyroid hormone related protein parathyroid hormones receptor expression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Bone is, together with kidney, the major target organ of PTH. It is
known that PTH increases bone turnover, but it is obscure why in vivo it
has an anabolic effect when it is administered intermittently, while its
catabolic action prevails when it is given in a continuous fashion. PTH
augments osteoclastic activity, but it is controversial whether its
effects on osteoclasts are only mediated through osteoblasts, or whether
they are also direct. Osteoblasts are the major target of PTH action.
Which cells, however, in the osteoblast lineage- a spectrum from
osteoprogenitors to pre-osteoblasts and mature osteoblasts - mediate the
various actions of PTH in vivo is an open question. It is also unknown
how PTHrP influenced osteoblast function independently of its role on
chondrocyte differentiation. Finally, the cloned PTH/PTHrP receptor is
able to activate at least two different signaling pathways, adenylate
cyclase and phospholipase C. However, their relative importance in
mediating the PTH effect on osteoblasts needs to be clarified. Recently
the identification of two different mutations in the PTH/PTHrP receptor
in patients with Jansen's metaphyseal chondrodysplasia (JMC), that lead
to ligand-independent constitutive cAMP accumulation, gave us a powerful
tool to explore experimentally at least some of the above mentioned
questions. We propose to develop transgenic mice in which mutant
PTH/PTHrP receptors will be expressed under the control of two different
promoters. alpha1(I) collagen and osteocalcin promoters, to allow their
targeted expression in less mature and/or more mature osteoblasts
respectively (Specific Aim I). The analysis of these animals will help
to determine and distinguish the roles of these cells in mediating the
response to PTH and PTHrP (Specific Aim II). We also propose to mate
these transgenic mice with the ones that selectively lack the PTH gene,
to identify PTH effects on osteoblast function and maturation that are
dependent on the PTH/PTHrP receptor activation of the cAMP pathway
(Specific Aim III). Lastly, we will mate the above described transgenic
mice with the animals that are resistant to collagenase-3 cleavage to
confirm the importance of collagenase-3 induction for the bone
remodeling process induced by PTH, both during development and in adult
life (Specific Aim IV).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hypoxia and mitochondria in spine development and congenital scoliosis
-
批准号:10640491
-
项目类别:
-
资助金额:$34.94万
-
财政年份:2023
-
负责人:Ernestina Schipani
-
依托单位:
2022 Bones and Teeth Gordon Research Conference and Seminar
-
批准号:10376959
-
项目类别:
-
资助金额:$1.58万
-
财政年份:2021
-
负责人:Ernestina Schipani
-
依托单位:
Regenerating Hyaline Cartilage Using Nanofibrous Hollow Microspheres and Synergizing TGF-beta and HIF
-
批准号:10337864
-
项目类别:
-
资助金额:$28.23万
-
财政年份:2020
-
负责人:Ernestina Schipani
-
依托单位:
Mitochondria and TFAM in Osteoblast Biology
-
批准号:10531537
-
项目类别:
-
资助金额:$38.76万
-
财政年份:2019
-
负责人:Ernestina Schipani
-
依托单位:
HIF-2alpha, a Novel Regulator of Osteoblastogenesis
-
批准号:10320694
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2019
-
负责人:Ernestina Schipani
-
依托单位:
HIF-2alpha, a Novel Regulator of Osteoblastogenesis
-
批准号:10536669
-
项目类别:
-
资助金额:$35.75万
-
财政年份:2019
-
负责人:Ernestina Schipani
-
依托单位:
HIF-2alpha, a Novel Regulator of Osteoblastogenesis
-
批准号:10391569
-
项目类别:
-
资助金额:$35.39万
-
财政年份:2019
-
负责人:Ernestina Schipani
-
依托单位:
Mitochondria and TFAM in Osteoblast Biology
-
批准号:9977917
-
项目类别:
-
资助金额:$23.02万
-
财政年份:2019
-
负责人:Ernestina Schipani
-
依托单位:
Mitochondria and TFAM in Osteoblast Biology
-
批准号:10361012
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2019
-
负责人:Ernestina Schipani
-
依托单位:
Core-001: Histological Assessment Core
-
批准号:9087505
-
项目类别:
-
资助金额:$25.76万
-
财政年份:2016
-
负责人:Ernestina Schipani
-
依托单位:
Exploring the Physiological Roles of Osteoblastic EPO and Osteoblastic EPOR
-
批准号:9107797
-
项目类别:
-
资助金额:$20.71万
-
财政年份:2015
-
负责人:Ernestina Schipani
-
依托单位:
HIF-1alpha, a Survival and Differentiation Factor for Cartilage
-
批准号:9115031
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2013
-
负责人:Ernestina Schipani
-
依托单位:
HIF-1alpha, a Survival and Differentiation Factor for Cartilage
-
批准号:8915052
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2013
-
负责人:Ernestina Schipani
-
依托单位:
HIF-1alpha, a Survival and Differentiation Factor for Cartilage
-
批准号:9329372
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2013
-
负责人:Ernestina Schipani
-
依托单位:
Identification of a novel population in the adult bone marrow
-
批准号:8336893
-
项目类别:
-
资助金额:$17.59万
-
财政年份:2011
-
负责人:Ernestina Schipani
-
依托单位:
Identification of a novel population in the adult bone marrow
-
批准号:8205157
-
项目类别:
-
资助金额:$20.98万
-
财政年份:2011
-
负责人:Ernestina Schipani
-
依托单位:
CORE--High-Resolution Histology
-
批准号:7432431
-
项目类别:
-
资助金额:$6.48万
-
财政年份:2007
-
负责人:Ernestina Schipani
-
依托单位:
CORE--High-Resolution Histology
-
批准号:6946653
-
项目类别:
-
资助金额:$8.16万
-
财政年份:2005
-
负责人:Ernestina Schipani
-
依托单位:
ROLE OF HYPOXIA IN DIFFERENTIATION
-
批准号:8053794
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2003
-
负责人:Ernestina Schipani
-
依托单位:
ROLE OF HYPOXIA IN DIFFERENTIATION
-
批准号:7466449
-
项目类别:
-
资助金额:$35.71万
-
财政年份:2003
-
负责人:Ernestina Schipani
-
依托单位:
海外基金